Alphatec Holdings, Inc. Overview
Pro stress-test →Alphatec Holdings is a medical technology company that designs, develops, and advances technologies for the surgical treatment of spinal disorders, manufacturing and selling implants, instruments, imaging equipment, and spare parts. The spine-focused company develops procedural ecosystems, imaging, and biologics to advance spine surgery.
Strategic Profile
Pro stress-test →The company achieved $764.16 million in revenue during 2025, a 24.95% increase versus 2024's $611.56 million. Strong surgeon adoption drove full-year 2024 surgical revenue growth of 29% with surgical volume growth of 19% and average revenue per procedure growth of 8%. 2026 guidance was raised for both revenue and Adjusted EBITDA, driven by innovation, surgeon adoption, and operational leverage.
Competitive Landscape
Pro stress-test →Alphatec competes in the specialized spine surgical device market against established medical technology companies offering spinal implants, fixation systems, and intraoperative monitoring solutions. Key competitors include manufacturers of competing spinal fusion systems, minimally invasive access platforms, and neuromonitoring technology providers serving orthopedic and neurosurgical customer bases.
Industry Context
Alphatec Holdings, Inc. operates in Spine surgical devices and implants.
Key facts
Founded: 2005 · Headquarters: Carlsbad, US · Revenue: $764.16M (2025) · Market cap: $1.6B